Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like from ProteoGenix; catalogue ARO-P12784; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like is a protein that plays a crucial role in the pathogenesis of Helicobacter pylori, a bacterium that is known to cause gastric ulcers and other gastrointestinal disorders. In this article, we will provide a detailed description of the structure, activity, and application of this recombinant protein, highlighting its potential as an antigen for diagnostic and therapeutic purposes.
Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like is a 46-kDa protein that belongs to the family of serine proteases. It is composed of 416 amino acids and has a conserved catalytic triad of serine, histidine, and aspartate, which is essential for its enzymatic activity. The protein has a modular structure, consisting of an N-terminal signal peptide, a transmembrane domain, and a C-terminal protease domain. The protease domain is further divided into three subdomains, namely, PDZ1, PDZ2, and PDZ3, which are responsible for substrate recognition and binding.
The primary function of Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like is to cleave and degrade misfolded or damaged proteins in the periplasmic space of H. pylori. This process is crucial for maintaining the integrity of the bacterial cell and preventing the accumulation of toxic protein aggregates. In addition to its proteolytic activity, this recombinant protein also has chaperone-like properties, which allow it to assist in the folding of newly synthesized proteins and prevent their aggregation.
Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like has several potential applications in the field of diagnostics and therapeutics. Some of these applications are discussed below:
The high specificity and immunogenicity of Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like make it an ideal candidate for the development of diagnostic tests for H. pylori infection. The presence of antibodies against this protein in the serum of infected individuals can serve as a biomarker for the diagnosis of H. pylori-associated diseases.
Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like has been identified as a potential vaccine candidate against H. pylori infection. Studies have shown that immunization with this protein can induce a strong immune response, leading to the production of antibodies that can neutralize the activity of H. pylori proteases and prevent bacterial colonization in the stomach.
The essential role of Recombinant Helicobacter pylori HP_1019/Periplasmic serine endoprotease DegP-like in the pathogenesis of H. pylori makes it an attractive target for the development of novel therapeutic agents. Inhibitors of this protein could potentially disrupt the bacterial cell membrane and inhibit its growth, making it a promising target for the treatment of H. pylori-associated diseases.
The modular structure of Recombinant Helicobacter pylori HP_101
ProteoGenix catalogue number ARO-P12784. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 0; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
